Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 117 of 1,261
  1. US 11987610

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. Β· Granted May 21, 2024 Β· Expires May 16, 2044

    granted
  2. US 11986454

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. Β· Granted May 21, 2024 Β· Expires May 16, 2044

    granted
  3. US 11986534

    Treatment of anthrax with pegylated capsule-degrading enzyme

    The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted May 21, 2024 Β· Expires May 16, 2044

    granted
  4. US 11986481

    Method of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. Β· Granted May 21, 2024 Β· Expires May 16, 2044

    granted
  5. US 11986533

    Macromonomers and bottle brush polymers for delivery of biological agents

    Regents of the University of Minnesota Β· Granted May 21, 2024 Β· Expires May 16, 2044

    granted
  6. US 11986515

    Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)

    REGENXBIO INC. Β· Granted May 21, 2024 Β· Expires May 16, 2044

    granted
  7. US 11986446

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals Ireland Limited Β· Granted May 21, 2024 Β· Expires May 16, 2044

    granted
  8. US 11987586

    Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists

    Takeda Pharmaceutical Company Limited Β· Granted May 21, 2024 Β· Expires May 16, 2044

    granted
  9. US 11987548

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. Β· Granted May 21, 2024 Β· Expires May 16, 2044

    granted
  10. US 11981752

    Tumor associated monocyte/macrophage binding peptide and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  11. US 11981760

    Therapeutic hydrogels and contact lens for corneal melting

    The Regents of the University of Colorado, a Body Corporate Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  12. US 11981739

    Chimeric antigen receptor specific for interleukin-23 receptor

    SANGAMO THERAPEUTICS FRANCE Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  13. US 11981912

    Adeno associated virus vectors for the treatment of hunter disease

    Takeda Pharmaceutical Company Limited Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  14. US 11981750

    Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s-type strains, derivatives and uses thereof

    The United States of America, as represented by the Secretary of Agriculture Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  15. US 11981736

    Antibodies specific to glycosylated PD-1 and methods of use thereof

    The Board of Regents of the University of Texas System Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  16. US 11981716

    Activatable interleukin-2 polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  17. US 11981684

    Macrocyclic compounds and uses thereof

    TURNING POINT THERAPEUTICS, INC. Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  18. US 11981724

    DNA antibody constructs for use against middle east respiratory syndrome coronavirus

    Inovio Pharmaceuticals, Inc. Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  19. US 11981730

    Anti-CXCL13 antibodies and methods of using the same

    VACCINEX, INC. Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  20. US 11980659

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Inovio Pharmaceuticals, Inc. Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  21. US 11981571

    Identification and optimization of carbon radicals on hydrated graphene oxide for ubiquitous antibacterial coatings

    The Regents of the University of California Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  22. US 11981662

    Pyrazole derivatives with anticancer activity

    The Board of Regents of the University of Texas System Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  23. US 11981897

    Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression

    Ionis Pharmaceuticals, Inc. Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted
  24. US 11982672

    Methods

    AUTOLUS LIMITED Β· Granted May 14, 2024 Β· Expires May 9, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.